Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Pharmaceutical and Biomedical Analysis|May 11, 2010
Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluidMartin Josefsson, Markus Roman, Elisabeth Skogh, et al.Journal of Clinical Psychopharmacology|December 31, 2010
High correlation between serum and cerebrospinal fluid olanzapine concentrations in patients with schizophrenia or schizoaffective disorder medicating with oral olanzapine as the only antipsychotic drugElisabeth Skogh, Ingemar Sjödin, Martin Josefsson, et al.Psychiatry Research|October 12, 2013
Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophreniaMartin Samuelsson, Elisabeth Skogh, Kristina Lundberg, et al.Therapeutic Drug Monitoring|July 27, 2002
Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical settingElisabeth Skogh, Margareta Reis, Marja-Liisa Dahl, et al.Acta Neuropsychiatrica|March 9, 2016
Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - correlation with monoamine metabolitesLinda K Nilsson-Todd, Conny Nordin, Erik G Jönsson, et al.Schizophrenia Bulletin|August 24, 2010
Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophreniaKlas R Linderholm, Elisabeth Skogh, Sara K Olsson, et al.International Journal of Tryptophan Research : IJTR|October 8, 2014
Imbalanced kynurenine pathway in schizophreniaMagdalena E Kegel, Maria Bhat, Elisabeth Skogh, et al.Journal of Psychiatry & Neuroscience : JPN|December 3, 2014
Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathwayLilly Schwieler, Markus K Larsson, Elisabeth Skogh, et al.Pageof 1